France· FR:65330992
DOXYLAMINE BIOGARAN CONSEIL 15 mg, comprimé pelliculé sécable
A medicinal product containing hydrogénosuccinate de doxylamine, registered in France by BIOGARAN.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- HYDROGÉNOSUCCINATE DE DOXYLAMINE
- Manufacturer
- BIOGARAN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400926689896tube(s) polypropylène de 10 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydrogénosuccinate de doxylamine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBasic Care Sleep AidAmazon.com Services LLC
- SpainDORMIDINA DOXILAMINA 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAEsteve Pharmaceuticals S.A.
- PolandBenosenSTADA Arzneimittel AG
- GermanyDolginox SchlaftropfenDr. Theiss Naturwaren Gmbh
- NorwayDormidina doxilaminaEsteve Pharmaceuticals S.A
- FinlandDormixOrion Corporation
- NetherlandsDoxylamine Geiser Pharma 12,5 mg poeder voor oraal gebruikGeiser Pharma S.L.
- BelgiumNavalit 10 mg - 10 mgEFFIK Benelux
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Hoggar Night
- Cyprus · Hoggar Night
- Germany · Dolginox Schlaftropfen, Doxylamin Dexcel
- Spain · Dormidina, Dormigen
- Finland · Dormix
- Greece · Hoggar Night
- Croatia · Hoggar
- Hungary · Hoggar
- Malta · Doxylamine Krka, Normodorm
- Norway · Zonat
- Poland · Benosen, Doksylamina Geiser
- Portugal · Dormidina, Hoggar
- Slovenia · Noctiben Mea
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6ba3a2e7-67c0-4a48-b18b-47f7403d23f0 GET /v1/drugs/6ba3a2e7-67c0-4a48-b18b-47f7403d23f0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65330992",
"date_amm": "2012-11-16",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "HYDROGÉNOSUCCINATE DE DOXYLAMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about hydrogénosuccinate de doxylamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.